240: #JPM23, the future of Alzheimer's, & rising Covid variants
The Readout Loud
00:00
The FDA Appropriation of Agile Home - What We Learned
CNN's John Defterios is back from maternity leave. He talks about the congressional investigation into biogen's ad to help people with dementia. Also, he looks at how Biogen set its $56,000 list price for Adjoham in June 2021. And what do you think? Share your thoughts on this episode of CNN iReport.
Transcript
Play full episode


